169 related articles for article (PubMed ID: 37160555)
1. Exosome-transmitted FOSL1 from cancer-associated fibroblasts drives colorectal cancer stemness and chemo-resistance through transcriptionally activating ITGB4.
Lin S; Zhu B
Mol Cell Biochem; 2024 Mar; 479(3):665-677. PubMed ID: 37160555
[TBL] [Abstract][Full Text] [Related]
2. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3.
Chen X; Liu J; Zhang Q; Liu B; Cheng Y; Zhang Y; Sun Y; Ge H; Liu Y
J Exp Clin Cancer Res; 2020 Apr; 39(1):65. PubMed ID: 32293494
[TBL] [Abstract][Full Text] [Related]
4. CAFs-secreted exosomal cricN4BP2L2 promoted colorectal cancer stemness and chemoresistance by interacting with EIF4A3.
Qu Z; Yang KD; Luo BH; Zhang F
Exp Cell Res; 2022 Sep; 418(2):113266. PubMed ID: 35752345
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts-derived exosome-mediated transfer of miR-345-5p promotes the progression of colorectal cancer by targeting CDKN1A.
Shi W; Liu Y; Qiu X; Yang L; Lin G
Carcinogenesis; 2023 Jun; 44(4):317-327. PubMed ID: 37052230
[TBL] [Abstract][Full Text] [Related]
6. ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.
Sung JS; Kang CW; Kang S; Jang Y; Chae YC; Kim BG; Cho NH
Oncogene; 2020 Jan; 39(3):664-676. PubMed ID: 31534187
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis.
Hu JH; Tang HN; Wang YH
Cancer Gene Ther; 2024 Feb; 31(2):259-272. PubMed ID: 38052858
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast-derived exosome miR-181b-3p promotes the occurrence and development of colorectal cancer by regulating SNX2 expression.
Jiang Y; Qiu Q; Jing X; Song Z; Zhang Y; Wang C; Liu K; Ye F; Ji X; Luo F; Zhao R
Biochem Biophys Res Commun; 2023 Jan; 641():177-185. PubMed ID: 36535076
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells.
Deng X; Ruan H; Zhang X; Xu X; Zhu Y; Peng H; Zhang X; Kong F; Guan M
Int J Cancer; 2020 Mar; 146(6):1700-1716. PubMed ID: 31381140
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a novel microfluidic co-culture system for simultaneous analysis of multiple indicators of gefitinib sensitivity in colorectal cancer cells.
Li X; Li W; Wang J; Wang Q; Liang M; Chen S; Ba W; Fang J
Mikrochim Acta; 2024 Apr; 191(5):279. PubMed ID: 38647729
[TBL] [Abstract][Full Text] [Related]
12. Exosomal LncRNA LINC00659 transferred from cancer-associated fibroblasts promotes colorectal cancer cell progression via miR-342-3p/ANXA2 axis.
Zhou L; Li J; Tang Y; Yang M
J Transl Med; 2021 Jan; 19(1):8. PubMed ID: 33407563
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
14. Exosomal-miR-522-3p derived from cancer-associated fibroblasts accelerates tumor metastasis and angiogenesis via repression bone morphogenetic protein 5 in colorectal cancer.
Zhang J; Pan Y; Jin L; Yang H; Cao P
J Gastroenterol Hepatol; 2024 Jan; 39(1):107-120. PubMed ID: 37984826
[TBL] [Abstract][Full Text] [Related]
15. Loss of exosomal miR-200b-3p from hypoxia cancer-associated fibroblasts promotes tumorigenesis and reduces sensitivity to 5-Flourouracil in colorectal cancer via upregulation of ZEB1 and E2F3.
Gong W; Guo Y; Yuan H; Chai R; Wan Z; Zheng B; Hu X; Chen B; Gao S; Dai Q; Yu P; Tu S
Cancer Gene Ther; 2023 Jun; 30(6):905-916. PubMed ID: 36890211
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-625-3p secreted by cancer-associated fibroblasts in colorectal cancer promotes EMT and chemotherapeutic resistance by blocking the CELF2/WWOX pathway.
Zhang Y; Yin C; Wei C; Xia S; Qiao Z; Zhang XW; Yu B; Zhou J; Wang R
Pharmacol Res; 2022 Dec; 186():106534. PubMed ID: 36336217
[TBL] [Abstract][Full Text] [Related]
17. MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway.
Ma D; Liu S; Liu K; Kong L; Xiao L; Xin Q; Jiang C; Wu J
Cancer Biol Ther; 2024 Dec; 25(1):2314324. PubMed ID: 38375821
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion.
Yan L; Wang P; Fang W; Liang C
Cell Biochem Funct; 2020 Apr; 38(3):257-265. PubMed ID: 31749189
[TBL] [Abstract][Full Text] [Related]
19. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
20. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
